Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to $443000.0.

  • Anika Therapeutics' Change in Inventory fell 8524.81% to $443000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.2 million, marking a year-over-year decrease of 12808.61%. This contributed to the annual value of $9.4 million for FY2024, which is 1730.43% down from last year.
  • Latest data reveals that Anika Therapeutics reported Change in Inventory of $443000.0 as of Q3 2025, which was down 8524.81% from -$1.7 million recorded in Q2 2025.
  • Over the past 5 years, Anika Therapeutics' Change in Inventory peaked at $4.7 million during Q2 2024, and registered a low of -$2.4 million during Q4 2024.
  • Over the past 5 years, Anika Therapeutics' median Change in Inventory value was $2.4 million (recorded in 2022), while the average stood at $1.7 million.
  • As far as peak fluctuations go, Anika Therapeutics' Change in Inventory soared by 69036.14% in 2022, and later crashed by 17617.08% in 2024.
  • Quarter analysis of 5 years shows Anika Therapeutics' Change in Inventory stood at -$498000.0 in 2021, then skyrocketed by 690.36% to $2.9 million in 2022, then rose by 6.77% to $3.1 million in 2023, then crashed by 176.17% to -$2.4 million in 2024, then surged by 118.53% to $443000.0 in 2025.
  • Its last three reported values are $443000.0 in Q3 2025, -$1.7 million for Q2 2025, and -$523000.0 during Q1 2025.